MedTrace Logo

Effectiveness of Enteral Nutrition for Dose Reduction of Low Dose PEG

NCT04021979 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 248

Last updated 2019-07-16

No results posted yet for this study

Summary

This clinical trial is being conducted to assess whether dietary restriction with enteral nutrition prescribed could prevent nonadherence to dietary restrictions, enable additional reduction of the required volume of PEG-ELS.

Conditions

  • Bowel Preparation

Interventions

DIETARY_SUPPLEMENT

Enteral Nutrition Powder Ensure

Enteral Nutrition Powder Ensure for each meal.The duration of study is one day before colonoscopy.

DRUG

1.5L PEG

Low volume PEG

OTHER

Self-controlled diet

Self-controlled low residue diet.

DRUG

2L PEG

Normal volume of PEG

Sponsors & Collaborators

  • Ningbo No. 1 Hospital

    lead OTHER

Principal Investigators

  • Hongpeng Lu, master · Department of Gastroenterology, Ningbo No. 1 Hospital, Ningbo, China

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-08-01
Primary Completion
2019-08-01
Completion
2019-11-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04021979 on ClinicalTrials.gov